After an inspection at the Pithampur plant, the USFDA issued a warning letter stating that the company's methods, facilities, or controls f...

The market regulator, in its letter to Aurobindo Pharma dated June 24, said the company had disclosed very limited and restricted informati...

The Sebi letter sent to the company on June 24, 2022 pertains to disclosures made by APL related to Official Action Indicated (OAI) and war...

The letter is in regards to certain disclosures made by the company on the ongoing USFDA audit of company's Unit-1 and observations made by...

This follows the earlier letter dated June 4, 2020, issuing an OAI (Official Action Indicated) status for this facility.

The scrip was trading 2.59 per cent lower at Rs 1,623 on the NSE.

USFDA had inspected the facility between April 15 and April 20, Glenmark said.

The Hyderabad-based company has been issued a warning letter by USFDA over significant violations of good manufacturing norms at its Nalgon...

The ban on all drugs made at Pithampur and Silvassa will continue until the company can demonstrate that the drugs from these sites are in ...

"What is 'closed' is the initial review that resulted in the warning letter issuance," Cadila Healthcare said.

The drug firm also said that the economic conditions in Venezuela continue to deteriorate further, increasing the risk of currency devaluat...

Shares of Sun Pharma surged over 3% in Wednesday's trade after the pharma giant issued clarification over the USFDA warning letter.

The warning letter issued by the US Food and Drug Administration will impact Dr Reddy's new drug approvals, the company said.

USFDA has issued a warning letter to Unimark Remedies for violating current good manufacturing practice norms at its plant near in Gujarat.

The US is the largest market for domestic generic companies, contributing 25-55% of revenues for large companies, while India supplies arou...

Mylan said the USFDA warning letter to Agila Specialties over violation of manufacturing norms in one of its plants will not affect the Rs ...

Sun Pharma's US arm, Caraco Pharmaceutical, will file a response to the US Food and Drug Administration's warning on its quality standards ...